CICC (03908) : "24 Zhongjin G1" coupon rate will be adjusted to 1.55%
CICC (03908) has issued an announcement. According to the provisions regarding the option to adjust the coupon rate in the "China International Capital Corporation Limited 2024 Public Issue Bond (First Tranche) Offering Circular for Professional Investors", the company has the right to decide at the end of the second year of the "24 CICC G1" period whether to adjust the coupon rate for the subsequent interest period of this tranche of bonds. Based on the actual situation of the company and the current market environment, the company has decided to reduce the coupon rate for the next 2 years by 84 basis points, meaning that the coupon rate for this tranche of bonds from March 4, 2026 to March 3, 2028 will be 1.55% (this tranche of bonds uses simple interest on an annual basis, not compound interest).
CICC (03908) announced that, in accordance with the "2024 Public Issuance Prospectus for Corporate Bonds (First Tranche) for Professional Institutional Investors of China International Capital Corporation Limited," the company has the right to decide at the end of the second year of the "24 Zhongjin G1" issuance period whether to adjust the coupon rate for the remaining interest payment periods of this tranche of bonds. Based on the company's actual situation and current market environment, the company has decided to lower the coupon rate for the next 2 years by 84 basis points. Therefore, the coupon rate of this tranche of bonds from March 4, 2026 to March 3, 2028 will be 1.55% (calculated on an annual basis without compounding).
In addition, investors have the option to sell back all or part of the bonds they hold to the issuer. This can be done by submitting a sell-back request through the Shanghai Stock Exchange trading system during the sell-back registration period: January 30, 2026 to February 5, 2026. The sell-back funds will be paid out on March 4, 2026.
Related Articles

CF PHARMTECH (02652) spent 395,000 Hong Kong dollars on February 2 to repurchase 11,000 shares.

MOKINGRAN (02585): The Stock Exchange of Hong Kong approves the listing of all H shares for full circulation.

Hainan Drinda New Energy Technology (02865) completed the issuance of a total of 18.682 million shares of placement shares.
CF PHARMTECH (02652) spent 395,000 Hong Kong dollars on February 2 to repurchase 11,000 shares.

MOKINGRAN (02585): The Stock Exchange of Hong Kong approves the listing of all H shares for full circulation.

Hainan Drinda New Energy Technology (02865) completed the issuance of a total of 18.682 million shares of placement shares.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


